Navigation Links
First tests of old patent medicine remedies from a museum collection
Date:4/7/2013

NEW ORLEANS, April 7, 2013 What was in Dr. F. G. Johnson's French Female Pills and other scientifically untested elixirs, nostrums and other quack cures that were the only medicines available to sick people during the 18th, 19th and early 20th centuries?

Scientists provided a glimpse today based on an analysis of a museum collection of patent medicines used in turn-of-the-century America. It was part of the 245th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society, which is being held here this week.

Mark Benvenuto, Ph.D, who headed the study, explained that hundreds of untested products were sold in stores, by mail order or in traveling medicine shows during the patent medicine era. The products were called "patent medicines" not because they had been granted a government patent, but from an unrelated term that originated in 17th century England.

"This was an era long before the controlled clinical trials and federal regulations that ensure the safety and effectiveness of the medicines we take today," Benvenuto explained. "Many patent medicines had dangerous ingredients, not just potentially toxic substances like arsenic, mercury and lead, but cocaine, heroin and high concentrations of alcohol."

The samples came from the collection of the Henry Ford Museum, in Dearborn, Mich. The museum houses artifacts celebrating American inventors of various items, including planes, cars, trains, machines, furniture and more. The 50 patent medicines in the analysis were among hundreds in the museum's Health Aids collection. The results of Benvenuto's study are on display at the museum.

Undergraduate students working under Benvenuto's supervision performed the bulk of the research. Andrew Diefenbach, a senior and mechanical engineering major at the university, presented the group's research in a talk here today. He got involved in the project as a freshman in Benvenuto's general chemistry course. "I'm interested to see what other comments people have, and what kind of things they may have thought of that we haven't thought of so far that we can use to further the research," Diefenbach said.

Some of the ingredients in the samples of old patent medicines, including calcium and zinc, actually could have been healthy and are mainstays in modern dietary supplements, said Benvenuto. He is with the University of Detroit Mercy. But others were clearly dangerous. Analysis of Dr. F. G. Johnson's French Female Pills, for instance, revealed iron, calcium and zinc. But the nostrum also contained lead, which is potentially toxic. Others contained mercury, another potentially toxic heavy metal, and arsenic.

Benvenuto explained that the presence of heavy metals may have been due to contamination. On the other hand, there actually was a rationale for including some of them. Arsenic and mercury were mainstays for treatment of syphilis, for instance.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
504-670-4707 (New Orleans Press Center, April 5-10)
202-872-6042

Michael Woods
m_woods@acs.org
504-670-4707 (New Orleans Press Center, April 5-10)
202-872-6293

American Chemical Society


Source:Eurekalert

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. Research reveals first evidence of hunting by prehistoric Ohioans
3. First model of how buds grow into leaves
4. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. First complete full genetic map of promising energy crop
7. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
8. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
9. New technology tracks sparrow migration for first time from California to Alaska
10. First mass extinction linked to marine anoxia
11. Scientists complete first-ever emperor penguin count from space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... Calif. , Nov. 23, 2016 Cercacor ... endurance athletes and their trainers non-invasively measure ... Index, Pulse Rate, and Respiration Rate in approximately 30 ... enables users easy and immediate access to key data ... part of a training regimen. Hemoglobin ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... BELLINGHAM, Washington, USA (PRWEB) , ... December 02, ... ... the role of innovative U.S.-owned and -operated small businesses in federally funded research ... SPIE, the international society for optics and photonics . , As part ...
(Date:12/4/2016)... , Dec. 3, 2016  In five studies ... Hematology (ASH) Annual Meeting and Exposition in ... engineering methods to improve the delivery of life-saving treatments ... new methods are designed to carry therapies directly to ... most, which could provide a substantial advantage over traditional, ...
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation of AxioMed’s ... disc production, company President, Jake Lubinski will be traveling to Switzerland from December ... in Bern, Lucerne, and Zurich to discuss the benefits of a viscoelastic disc. ...
(Date:12/2/2016)... -- The Multiple Myeloma Research Foundation (MMRF) today announced that ... —the largest and most comprehensive study driving new genomic ... presented at the 58 th American Society of ... San Diego from December 3-6. The new ... as identify pathways and targets for new drug development. ...
Breaking Biology Technology: